AMP-activated protein kinase activation suppresses leptin expression independently of adipogenesis in primary murine adipocytes

Author:

Bustraan Sophia12,Bennett Jane2,Whilding Chad2,Pennycook Betheney R.2,Smith David3,Barr Alexis R.12,Read Jon4,Carling David12ORCID,Pollard Alice1ORCID

Affiliation:

1. 1Institute of Clinical Sciences, Faculty of Medicine, Imperial College London, London, U.K.

2. 2Medical Research Council Laboratory of Medical Sciences, London, U.K.

3. 3Emerging Innovations Unit, Discovery Sciences, R&D, AstraZeneca, Cambridge, U.K.

4. 4Mechanistic and Structural Biology, Biopharmaceuticals R&D, AstraZeneca, Cambridge, U.K.

Abstract

Adipogenesis, defined as the development of mature adipocytes from stem cell precursors, is vital for the expansion, turnover and health of adipose tissue. Loss of adipogenic potential in adipose stem cells, or impairment of adipogenesis is now recognised as an underlying cause of adipose tissue dysfunction and is associated with metabolic disease. In this study, we sought to determine the role of AMP-activated protein kinase (AMPK), an evolutionarily conserved master regulator of energy homeostasis, in adipogenesis. Primary murine adipose-derived stem cells were treated with a small molecule AMPK activator (BI-9774) during key phases of adipogenesis, to determine the effect of AMPK activation on adipocyte commitment, maturation and function. To determine the contribution of the repression of lipogenesis by AMPK in these processes, we compared the effect of pharmacological inhibition of acetyl-CoA carboxylase (ACC). We show that AMPK activation inhibits adipogenesis in a time- and concentration-dependent manner. Transient AMPK activation during adipogenic commitment leads to a significant, ACC-independent, repression of adipogenic transcription factor expression. Furthermore, we identify a striking, previously unexplored inhibition of leptin gene expression in response to both short-term and chronic AMPK activation irrespective of adipogenesis. These findings reveal that in addition to its effect on adipogenesis, AMPK activation switches off leptin gene expression in primary mouse adipocytes independently of adipogenesis. Our results identify leptin expression as a novel target of AMPK through mechanisms yet to be identified.

Funder

UKRI | Biotechnology and Biological Sciences Research Council

UKRI | Medical Research Council

Cancer Research UK

Publisher

Portland Press Ltd.

Reference72 articles.

1. WHO. (2023) World health statistics 2023: monitoring health for the SDGs, Sustainable Development Goals. World Health Organization, Geneva.

2. Health Survey for England, 2021–2022. Available from: https://digital.nhs.uk/data-and-information/publications/statistical/health-survey-for-england/2021/overweight-and-obesity-in-adults

3. NHS Digital. (2020) Statistics on obesity, physical activity and diet, England, 2020

4. Fat fighting liraglutide based nano-formulation to reverse obesity: design, development and animal trials;Int. J. Pharm.,2023

5. Semaglutide: a new drug for the treatment of obesity;Drug Ther. Bull.,2023

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3